↓ Skip to main content

A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer

Overview of attention for article published in Breast Cancer Research, December 2019
Altmetric Badge

Readers on

mendeley
64 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer
Published in
Breast Cancer Research, December 2019
DOI 10.1186/s13058-019-1178-0
Pubmed ID
Authors

Iain R. Macpherson, Pavlina Spiliopoulou, Saeed Rafii, Matilde Saggese, Richard D. Baird, Javier Garcia-Corbacho, Antoine Italiano, Jacques Bonneterre, Mario Campone, Nicola Cresti, John Posner, Yousuke Takeda, Akinori Arimura, James Spicer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 64 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 16%
Researcher 8 13%
Student > Master 5 8%
Other 4 6%
Lecturer 3 5%
Other 10 16%
Unknown 24 38%
Readers by discipline Count As %
Medicine and Dentistry 14 22%
Biochemistry, Genetics and Molecular Biology 6 9%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Nursing and Health Professions 3 5%
Economics, Econometrics and Finance 3 5%
Other 6 9%
Unknown 27 42%